Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial

Erstveröffentlichung
2009Authors
Ridker, Paul M.
Danielson, Eleanor
Fonseca, Francisco A. H.
Genest, Jacques
Gotto, Jr., Antonio M.
Wissenschaftlicher Artikel
Published in
Obstetrical & Gynecological Survey ; 64 (2009), 9. - S. 596-597. - ISSN 0029-7828. - eISSN 1533-9866